Behaviour and evolutionary responses to pharmaceutical pollution

对药物污染的行为和进化反应

• 批准号: DP160100372
• 负责人: Prof Bob Wong
• 金额: $ 25.8万
• 依托单位: Monash University
• 依托单位国家: 澳大利亚
• 项目类别: Discovery Projects
• 财政年份: 2016
• 资助国家: 澳大利亚
• 起止时间: 2016-01-01 至 2018-12-31
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/DP160100372
• 关键词: Behaviour; evolutionary; responses; pharmaceutical; pollution

This project aims to uncover how a ubiquitous pharmaceutical pollutant – fluoxetine, known as Prozac – alters the course of reproduction and sexual selection in a freshwater fish. Drugs used in human and veterinary medicine enter the environment and pose a serious threat to wildlife. The project plans to integrate morphological, behavioural, and experimental evolution approaches to yield insights into how fluoxetine affects sexual traits and behaviours, and how this in turn can affect offspring viability and the evolutionary process. Findings are expected to add to our understanding of how species respond to rapidly changing environments, with consequences for the persistence of populations and the survival of species in the wild.

该项目旨在揭示一种无处不在的药物污染物--氟西汀，也就是所谓的百忧解--如何改变淡水鱼的繁殖和性选择过程。用于人类和兽医的药物进入环境，对野生动物构成严重威胁。该项目计划整合形态、行为和实验进化方法，以深入了解氟西汀如何影响性特征和行为，以及这反过来如何影响后代的生存能力和进化过程。这些发现有望增加我们对物种如何对快速变化的环境做出反应的理解，从而对种群的持续存在和物种在野外的生存产生影响。